Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy & Safety of Nasal Influenza Immunisation in Children (SNIFFLE-3)
2015-003019-39Phase 4Completed
- Start
- Jul 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4 trial of live attenuated influenza vaccine in influenza (2 arms). Primary endpoint: Incidence of laboratory-confirmed influenza and other respiratory viruses. Started Jul 2015; status: completed.
02
Drugs
live attenuated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2015-003019-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003019-39.